Cobalt represented JSC E energija on the deal. JSC E energija, completed the sale of the largest wind farm of the E energija Group to JSC...
JSC Ignitis Renewables’ Acquisition of E Energija Group
Blackbaud’s Settling of Multi-State Attorneys General Investigation
Blank Rome represented Blackbaud on its 2020 security incident. Blackbaud (NASDAQ: BLKB), the leading provider of software for powering social impact, has reached a settlement with...
Lexeo Therapeutics’ $100 Million Initial Public Offering
Paul Hastings LLP advised the underwriters in connection with Lexeo Therapeutics’ IPO. Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to transforming...
Air Methods’ Chapter 11 Restructuring and Recapitalization
McDermott Will & Emery is advising Wilmington Savings Fund Society, FSB, as the DIP Agent, on the restructuring, Milbank is advising Royal Bank of Canada, as...
Blackstone’s Acquisition of Majority Stake in CARE Hospitals
Debevoise & Plimpton advised Evercare Group on the transaction. US-based private equity firm Blackstone has announced it entered into the Indian healthcare market by acquiring a majority...
Quantum’s Midstream Partnership with Comstock
Kirkland & Ellis counseled Quantum Capital Solutions on the transaction. Quantum Capital Solutions (“QCS”), an affiliate of Quantum Capital Group announced the formation of a midstream partnership...
Brookfield and Copley Point Capital’s Acquisition of UK Airport Logistics Assets
Ropes & Gray advised Brookfield on the transaction. Brookfield’s real estate solutions business partnered with U.K. industrial real estate manager Copley Point Capital to acquire three warehouses...
MapLight Therapeutics’ $225 Million Series C Funding Round
Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction. MapLight Therapeutics announced a $225 million Series C financing co-led by Novo Holdings, 5AM Ventures, Cowen...
Verve Therapeutics’ Relationship Expansion with Lilly
Wilson Sonsini Goodrich & Rosati advised Verve Therapeutics on IP matters related to the transaction. Verve Therapeutics, Inc. (Nasdaq:VERV) announced the expansion of its relationship with Eli Lilly...
Samara’s $41 Million Series A Financing Round
Fenwick & West advised Samara on the transaction. Samara announced its $41 million Series A financing. The round was led by Thrive Capital with participation from 8VC,...
Atara Biotherapeutics’ Partnership with Pierre Fabre Laboratories
Fenwick & West represented Atara Biotherapeutics, Inc. in the transaction. Atara Biotherapeutics, Inc. (Nasdaq: ATRA) announced it has entered into an expanded partnership with Pierre Fabre...
Brynwood Partners’ Closing of Ninth Fund at $750 Million
Locke Lord represented Brynwood Partners on the deal. Brynwood Partners (Brynwood) announced it closed its ninth fund, Brynwood Partners IX L.P., with over $750 million of committed capital. With...